Utilization of hypnotic medication in the context of cancer: Predictors and frequency of use

Supportive Care in Cancer

Volumn 20, Issue 6, 2012, Pages 1203-1210

  Casault, Lucie ^a   Savard, Josée ^a   Ivers, Hans ^a   Savard, Marie Hélène ^a   Simard, Sébastien ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cancer; Hypnotic medication; Insomnia; Predictors

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CITALOPRAM; CLONAZEPAM; DIAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MIRTAZAPINE; NARCOTIC ANALGESIC AGENT; NATURAL PRODUCT; NITRAZEPAM; NON PRESCRIPTION DRUG; OXAZEPAM; PAROXETINE; SERTRALINE; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRIMIPRAMINE; VENLAFAXINE; ZALEPLON; ZOPICLONE;

ADULT; AGE; AGED; ANXIETY; ARTICLE; BREAST CANCER; CANADA; CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; DRUG UTILIZATION; FEMALE; HUMAN; INSOMNIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; RANDOM SAMPLE; STRESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NEOPLASMS; QUEBEC; QUESTIONNAIRES; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84863989259     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1199-4     Document Type: Article

References (53)

1. Savard J, Villa J, Ivers H, Simard S, Morin CM (2009) Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol 27(31):5233-5239
2. Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM (2011) Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol (in revision)
3. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C (2006) Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 7(2):123-130
4. National Institutes of Health (2005) National institutes of health state-of-the-science conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 28(9):1049-1057
5. Morin CM (2001) Psychological and pharmacological treatments for insomnia. In: Sammons M, Schmidt NB (eds) Combining psychological and pharmacological treatments for mental disorders: a guide for psychologists. American Psychological Association, Washington
6. Hajak G, Clarenbach P, Fischer W, Rodenbeck A, Bandelow B, Broocks A, Ruther E (1998) Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur Arch Psychiatry Clin Neurosci 248(3):148-156 (Pubitemid 28396010)
7. Brands B, Sproule B, Marshman J (1998) CNS depressants: sedative/hypnotics and anxiolytics. In: Brands B, Sproule B, Marshman J (eds) Drugs & drug abuse. Addiction Research Foundation, Toronto
8. Barbeau G, Guimond J, Mallet L (1991) Médicaments et personnes âgées. Edisem, Québec
9. Hall N (1998) Taking policy action to reduce benzodiazepine use and promote self-care among seniors. J Appl Gerontol 17(3):318-351 (Pubitemid 28374543)
10. Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 162(2):225-233 (Pubitemid 30073249)
11. Ohayon MM, Caulet M (1996) Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 41:457-464 (Pubitemid 26352974)
12. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L (1998) Mortality hazard associated with prescription hypnotics. Biol Psychiatry 43:687-693 (Pubitemid 28222390)
13. Derogatis LR, Feldstein M, Morrow G, Schmale A, Schmitt M, Gates C, Murawski B, Holland J, Penman D, Melisaratos N, Enelow AJ, Adler LM (1979) A survey of sychotropic drug prescriptions in an oncology population. Cancer 44:1919-1929 (Pubitemid 10141975)
14. Jaeger H, Morrow GR, Carpenter PJ, Brescia F (1985) A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp Psych 7(4):353-360 (Pubitemid 16220849)
15. Stiefel FC, Kornblith AB, Holland JC (1990) Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 65:1048-1053 (Pubitemid 20063514)
16. Paltiel O, Marzec-Bogulawska A, Soskolne V, Massalha S, Avitzour M, Pfeffer R, Cherny N, Peretz T (2004) Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Qual Life Res 13:1699-1706 (Pubitemid 41215249)
17. Davidson JR, MacLean AW, Brundage MD, Schulze K (2002) Sleep disturbance in cancer patients. Soc Sci Med 54:1309-1321 (Pubitemid 34240048)
18. van Hulten R, Leufkens HG, Bakker A (1998) Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. Pharm World Sci 20(2):78-82 (Pubitemid 28228438)
19. Ohayon MM, Caulet M (1995) Insomnia and psychotropic drug consumption. Prog Neuropsychopharmacol Biol Psychiatry 19 (3):421-431
20. Zandstra SM, Furer JW, van de Lisdonk EH, Bor JH, Zitman FG, van Weel C (2002) Differences in health status between long-term and short-term benzodiazepine users. Br J Gen Pract 52(483):805-808
21. Koopman C, Nouriani B, Erickson V, Anupindi R, Butler LD, Bachmann MH, Sephton SE, Spiegel D (2002) Sleep disturbances in women with metastatic breast cancer. Breast J 8 (6):362-370 (Pubitemid 35334651)
22. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B (2001) Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 57(5):419-425 (Pubitemid 33787193)
23. Jorm AF, Grayson D, Creasey H, Waite L, Broe GA (2000) Longterm benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 24(1):7-10 (Pubitemid 30113593)
24. Blennow G, Romelsjo A, Leifman H, Leifman A, Karlsson G (1994) Sedatives and hypnotics in Stockholm: social factors and kinds of use. Am J Public Health 84(2):242-246 (Pubitemid 24138459)
25. Magrini N, Vaccheri A, Parma E, D'Alessandro R, Bottoni A, Occhionero M, Montanaro N (1996) Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 50(1-2):19-25 (Pubitemid 26141503)
26. Gutierrez-Lobos K, Frohlich S, Miller C, Whitworth AB, Quiner S, Barnas C (2000) A comparison of patterns of tranquiliser intake, anxiety and health locus of control between short- and long-term benzodiazepine users. Neuropsychobiology 42(4):187-191
27. Mallon L, Hetta J (1997) A survey of sleep habits and sleeping difficulties in an elderly Swedish population. Ups J Med Sci 102 (3):185-197
28. Asplund R (1995) Sleep and hypnotics among the elderly in relation to body weight and somatic disease. J Intern Med 238 (1):65-70
29. Roehrs T, Hollebeek E, Drake C, Roth T (2002) Substance use for insomnia in Metropolitan Detroit. J Psychosom Res 53(1):571-576
30. National Cancer Institute of Canada (2005) Canadian cancer statistics 2005. National Cancer Institute of Canada, Toronto
31. Morin CM (1993) Insomnia: psychological assessment and management. Guilford, New York
32. Savard MH, Savard J, Simard S, Ivers H (2005) Empirical validation of the insomnia severity index in cancer patients. Psychooncology 14(6):429-441 (Pubitemid 40883415)
33. Bastien CH, Vallières A, Morin CM (2001) Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2(4):297-307 (Pubitemid 32677404)
34. Smith S, Trinder J (2001) Detecting insomnia: comparison of four self-report measures of sleep in a young adult population. J Sleep Res 10:229-235 (Pubitemid 32823906)
35. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361-370 (Pubitemid 13098606)
36. Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG (1998) Evaluating anxiety and depression in HIV-infected patients. J Pers Assess 71:349-367 (Pubitemid 29066373)
37. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes dJCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a qualityof-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376 (Pubitemid 23073154)
38. Fillion L, Kohn P, Gagnon P, Van Wijk M, Cunningham A (2001) The inventory of recent life experiences for cancer patients (IRLEC): a decontaminated measure of cancer-based hassles. Psychol Heal 16(4):443-459 (Pubitemid 33691190)
39. Brugha TS, Cragg D (1990) The list of threatening experiences: the reliability and validity of a brief life events questionnaire. Acta Psychiatr Scand 82:77-81 (Pubitemid 20244547)
40. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326-1336 (Pubitemid 24322071)
41. SAS Institute (2004) SAS/STAT 9.1 user's guide, vol 1 to 7. SAS Institute, Cary, NC
42. Canada S (1994) Canada's Alcohol and other Drug Survey. http://www.statcan.gc.ca/dli-ild/data-donnees/ftp/cads-eccad/cads-eccad1994-eng. htm
43. Frighetto L, Marra C, Bandali S, Wilbur K, Naumann T, Jewesson P (2004) An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients. Health Quality of Life Outcomes 2(1):17
44. Espie CA (1999) Cognitive behaviour therapy as the treatment of choice for primary insomnia. Sleep Med Rev 3(2):97-99 (Pubitemid 29284708)
45. Morin CM, Culbert JP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151(8):1172-1180 (Pubitemid 24240960)
46. Savard J, Simard S, Ivers H, Morin CM (2005) Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer: I - sleep and psychological effects. J Clin Oncol 23(25):6083-6095
47. Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J (2008) Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 26(28):4651-4658
48. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 29 (11):1398-1414 (Pubitemid 44764665)
49. Savard J, Villa J, Simard S, Ivers H, Morin CM (2010) Feasibility of a self-help treatment for insomnia comorbid with cancer. Psychooncology [Epub ahead of print]
50. Johnson EO, Roehrs T, Roth T, Breslau N (1998) Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 21:178-186 (Pubitemid 128470363)
51. Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. Support Care Cancer 5:307-313 (Pubitemid 27305081)
52. Morin CM, Espie CA (2003) Insomnia: a clinical guide to assessment and treatment. Kluwer/Plenum, New York
53. Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, Rock CL, Pierce JP (2008) The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology 17(1):9-18 (Pubitemid 351166272)